rs1800625 — AGER AGER -429T>C

Promoter variant at position -429 in the AGER gene linked to diabetic complications, cancer susceptibility, and sepsis risk

See your personal result for AGER

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

AGER -429T>C — The Promoter Variant That Turns Up RAGE Signaling

The AGER gene encodes RAGE (Receptor for Advanced Glycation End-Products), a pattern recognition receptor11 pattern recognition receptor
A cell-surface protein in the immunoglobulin superfamily that detects molecular damage signals — AGEs, HMGB1, S100 proteins, amyloid-beta — and triggers sustained NF-κB-mediated inflammatory gene expression sitting in the MHC class III region22 MHC class III region
The Major Histocompatibility Complex class III locus on chromosome 6p21.3 — a gene-dense stretch encoding many immunoinflammatory regulators, tightly linked to immune response haplotypes including the 8.1 ancestral haplotype associated with autoimmune susceptibility of chromosome 6. RAGE is expressed on endothelial cells, immune cells, neurons, alveolar epithelium, adipocytes, and cardiomyocytes. When its ligands bind — particularly advanced glycation end-products (AGEs) formed from proteins and lipids modified by sugars — RAGE activates NF-κB and MAPK cascades, driving a self-amplifying inflammatory loop.

The rs1800625 variant sits 429 base pairs upstream of the AGER transcription start site in the gene's promoter region. The G allele (described in older literature as the -429C allele using coding-strand notation, because AGER is on the minus strand) alters transcription factor binding at the promoter.

The Mechanism

The AGER promoter contains functional binding sites for NF-κB and SP1 transcription factors. The -429T>C transition (plus-strand A>G) lies within a regulatory element that modulates baseline and stimulus-driven RAGE transcription.

The rs1800625 variant is part of the HLA 8.1 ancestral haplotype33 HLA 8.1 ancestral haplotype
A conserved MHC haplotype (carrying HLA-A1, HLA-B8, HLA-DR3, HLA-DQ2) found in ~8-10% of Northern Europeans and strongly associated with multiple autoimmune conditions including type 1 diabetes, celiac disease, and systemic lupus erythematosus, as documented by Laki et al. (2007)44 Laki et al. (2007)
Laki J et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C RAGE gene polymorphism. Oral Dis, 2006. This haplotype context complicates causal interpretation — some disease associations attributed to the -429C/G variant may partly reflect co-inherited immune-related variants in the broader 8.1 haplotype.

The Evidence

Glycemic control. Laki et al. (2007) studied 82 unrelated type 1 diabetic patients and found that the -429C/G allele was independently associated with elevated HbA1c55 independently associated with elevated HbA1c levels regardless of haplotype status, suggesting a direct functional effect on glycemic trajectory beyond the 8.1 haplotype association.

Diabetic complications. A Pakistani study by Qayyum et al. (2021)66 Qayyum et al. (2021)
Qayyum A et al. Association analysis of -429T/C RAGE gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels. J Pak Med Assoc, 2021 found that the C/G allele was associated with higher circulating sRAGE.

Cancer susceptibility. A meta-analysis by Xu et al. (2019)77 Xu et al. (2019)
Xu Y et al. Association of RAGE rs1800625 polymorphism and cancer risk: A meta-analysis of 18 case-control studies. Med Sci Monit, 2019 pooled 6,246 cancer cases and 6,819 controls from 18 studies. The CC/GG homozygous genotype was associated with increased cancer risk in the recessive model (OR=1.40, 95%CI 1.03–1.89, P=0.031), with the association driven predominantly by Asian populations; Caucasian-specific analysis did not reach significance. Cancer types studied included gastric, colorectal, lung, and liver cancers.

Sepsis and trauma. A prospective Chinese study by Zeng et al. (2015)88 Zeng et al. (2015)
Zeng L et al. Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma. Crit Care, 2015 found that the C/G allele was associated with lower sepsis morbidity and reduced multiple organ dysfunction syndrome (MODS) scores. Carriers of the CC/GG genotype had significantly fewer sepsis-related complications than TT/AA homozygotes — an apparently protective effect in acute inflammatory stress.

Practical Actions

The primary actionable target is the AGE load that activates RAGE. Dietary AGEs — formed by high-heat dry cooking of proteins and fats — are absorbed and bind RAGE directly. Switching to moist-heat cooking (boiling, steaming, slow cooking, poaching) reduces dietary AGE intake by 50–70%. Controlling blood glucose is equally important: chronic hyperglycemia accelerates endogenous AGE formation. Monitoring HbA1c is particularly relevant given the variant's association with glycemic excursions and diabetic complication risk.

Genotype Interpretations

What each possible genotype means for this variant.

AA Standard RAGE Promoter Normal

Common promoter genotype with typical RAGE transcriptional activity

With the AA genotype, the AGER promoter at position -429 maintains its baseline transcription factor binding profile without the altered binding that the G allele introduces. Your circulating and membrane RAGE levels at this locus reflect typical population expression, meaning the AGE-RAGE- NF-κB inflammatory loop operates at its standard baseline rate.

This does not mean RAGE signaling is irrelevant to you — all humans accumulate AGEs with age, diabetes, and high-heat diet exposure, and membrane RAGE activation is a universal inflammatory driver.

AG RAGE Promoter Carrier Intermediate

One copy of the promoter variant — moderately elevated RAGE transcription

The rs1800625 G allele in heterozygous form is associated with the HLA 8.1 ancestral haplotype in many European populations, which itself carries elevated autoimmune susceptibility. If you have a personal or family history of autoimmune conditions, this haplotype context may be relevant.

The 2019 cancer meta-analysis found that pooled analyses favored a recessive model (GG vs TC+TT), so heterozygote cancer risk findings are less consistent.

GG RAGE Promoter Risk Genotype High Risk

Two copies of the upregulatory promoter variant — elevated RAGE transcription and inflammatory signaling capacity

The cancer risk finding from the Xu et al. (2019) meta-analysis used a recessive model where GG homozygotes showed OR=1.40 for cancer susceptibility across 18 studies (6,246 cases).

The HbA1c association is notable because it suggests that beyond baseline diabetes risk, the GG genotype may impair glycemic control in people who already have diabetes.

In the sepsis and major trauma context, the C/G allele paradoxically appeared protective (lower MODS scores) in the Zeng et al. (2015) trauma study.

The haplotype context matters: in Northern Europeans, GG carriers at this locus often co-inherit the HLA 8.1 ancestral haplotype, which independently elevates autoimmune risk. If you have European ancestry, checking your HLA haplotype may provide additional context.